Liu J, Tian Y, Fu X, Mu C, Yao M, Ni Y, Liu Y et al (2022) Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis. Chin Med J 135(14):1682-1691

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang TD, Behary J, Zekry A (2019) Non-alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management. Intern Med J 50(9):1038–1047

Article  Google Scholar 

Cai C, Song X, Chen Y, Chen X, Yu C (2020) Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Hepatol Int 14(1):115–126

Article  PubMed  Google Scholar 

Kim JA, Choi KM (2019) Sarcopenia and fatty liver disease. Hepatol Int 13(6):674–687

Article  CAS  PubMed  Google Scholar 

Alferink LJM, Trajanoska K, Erler NS, Schoufour JD, de Knegt RJ, Ikram MA, Janssen HLA et al (2019) Nonalcoholic fatty liver disease in the Rotterdam Study: about muscle mass, sarcopenia, fat mass, and fat distribution. J Bone Miner Res 34(7):1254–1263

Article  CAS  PubMed  Google Scholar 

Seko Y, Mizuno N, Okishio S, Takahashi A, Kataoka S, Okuda K, Furuta M et al (2019) Clinical and pathological features of sarcopenia-related indices in patients with non-alcoholic fatty liver disease. Hepatol Res 49(6):627–636

Article  CAS  PubMed  Google Scholar 

Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, Lee KL et al (2017) Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol 66(1):123–131

Article  PubMed  Google Scholar 

Lee HJ, Chang JS, Ahn JH, Kim MY, Park K-S, Ahn Y-S, Koh SB (2021) Association between low muscle mass and non-alcoholic fatty liver disease diagnosed using ultrasonography, magnetic resonance imaging derived proton density fat fraction, and comprehensive NAFLD score in Korea. J Prev Med Public Health 54(6):412–421

Article  PubMed  PubMed Central  Google Scholar 

Almeida NS, Rocha R, de Souza CA, da Cruz ACS, Ribeiro BDR, Vieira LV, Daltro C et al (2022) Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease. World J Hepatol 14(8):1643–1651

Article  PubMed  PubMed Central  Google Scholar 

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Aging 48(1):16–31

Article  Google Scholar 

Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerentol 69(5):547–558

Article  Google Scholar 

Peng T-C, Wu L-W, Chen W-L, Liaw F-Y, Chang Y-W, Kao T-W (2019) Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III): the importance of sarcopenia definition. Clin Nutr 38(1):422–428

Article  PubMed  Google Scholar 

Meng NH, Li CI, Liu CS, Lin CH, Lin WY, Chang CK, Li TC et al (2015) Comparison of height-and weight-adjusted sarcopenia in a Taiwanese metropolitan older population. Geriatr Gerontol Int 15(1):45–53

Article  PubMed  Google Scholar 

Gan D, Wang L, Jia M, Ru Y, Ma Y, Zheng W, Zhao X et al (2020) Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. Clin Nutr 39(4):1124–1130

Article  PubMed  Google Scholar 

Wang Y-M, Zhu K-F, Zhou W-J, Zhang Q, Deng D-F, Yang Y-C, Lu W-W et al (2021) Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study. BMC Geriatr 21(1):55

Article  CAS  PubMed  PubMed Central  Google Scholar 

Linge J, Ekstedt M, Leinhard OD (2021) Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD. JHEP Rep 3(1):100197

Article  PubMed  Google Scholar 

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779

Article  PubMed  PubMed Central  Google Scholar 

National Health Service: Alcohol Units—NHS; 2021. https://www.nhs.uk/live-well/alcohol-advice/calculating-alcohol-units/. Accessed 11 Nov 2022

Dixon WT (1984) Simple proton spectroscopic imaging. Radiology 153(1):189–194

Article  CAS  PubMed  Google Scholar 

Wilman HR, Kelly M, Garratt S, Matthews PM, Milanesi M, Herlihy A, Gyngell M et al (2017) Characterisation of liver fat in the UK Biobank cohort. PLoS ONE 12(2):e0172921

Article  PubMed  PubMed Central  Google Scholar 

Glover GH (1991) Multipoint Dixon technique for water and fat proton and susceptibility imaging. J Magn Reson Imaging 1(5):521–530

Article  CAS  PubMed  Google Scholar 

Ahn SB, Jun DW, Kang B-K, Kim M, Chang M, Nam E (2018) Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting. Medicine 97(50):e13636

Article  PubMed  PubMed Central  Google Scholar 

Dodds RM, Granic A, Robinson SM, Sayer AA (2020) Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants. J Cachexia Sarcopenia Muscle 11(1):62–68

Article  PubMed  Google Scholar 

Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35(8):1381–1395

Article  PubMed  Google Scholar 

Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the kappa statistic. Fam Med 37(5):360–363

PubMed  Google Scholar 

Safari S, Baratloo A, Elfil M, Negida A (2015) Evidence based emergency medicine part 2: positive and negative predictive values of diagnostic tests. Emerg 3(3):87–88

Google Scholar 

Martone AM, Marzetti E, Salini S, Zazzara MB, Santoro L, Tosato M, Picca A et al (2020) Sarcopenia identified according to the EWGSOP2 definition in community-living people: prevalence and clinical features. J Am Med Dir Assoc 21(10):1470–1474

Article  PubMed  Google Scholar 

Dietzel R, Wiegmann S, Borucki D, Detzer C, Zeiner KN, Schaumburg D, Buehring B et al (2022) Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition. RMD Open 8(2):e002600

Article  PubMed  PubMed Central  Google Scholar 

Sobestiansky S, Michaelsson K, Cederholm T (2019) Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85–89 year old community-dwelling men: a report from the ULSAM study. BMC Geriatr 19(1):318

Article  PubMed  PubMed Central  Google Scholar 

Su Y, Hirayama K, Han T-F, Izutsu M, Yuki M (2019) Sarcopenia prevalence and risk factors among Japanese community dwelling older adults living in a snow-covered city according to EWGSOP2. J Clin Med 8(3):291

Article  PubMed  PubMed Central  Google Scholar 

Moreno-Gonzalez R, Corbella X, Mattace-Raso F, Tap L, Sieber C, Freiberger E, Kostka T et al (2020) Prevalence of sarcopenia in community-dwelling older adults using the updated EWGSOP2 definition according to kidney function and albuminuria. BMC Geriatr 20(1):327

Article  PubMed  PubMed Central  Google Scholar 

Pacifico J, Geerlings MA, Reijnierse EM, Phassouliotis C, Lim WK, Maier AB (2020) Prevalence of sarcopenia as a comorbid disease: a systematic review and meta-analysis. Exp Gerentol 131(3):110801

Article  Google Scholar 

Lee K (2018) Relationship between handgrip strength and nonalcoholic fatty liver disease: nationwide surveys. Metab Syndr Relat Disord 16(9):497–503

Article  CAS  PubMed  Google Scholar 

Meng G, Wu H, Fang L, Li C, Yu F, Zhang Q, Liu L et al (2016) Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population. Sci Rep 6(1):1–7

Article  Google Scholar 

Park SH, Kim DJ, Plank LD (2020) Association of grip strength with non-alcoholic fatty liver disease: investigation of the roles of insulin resistance and inflammation as mediators. Eur J Clin Nutr 74(10):1401–1409

Article  CAS  PubMed  Google Scholar 

Seo JY, Cho EJ, Kim MJ, Kwak M-S, Yang JI, Chung SJ, Yim JY et al (2022) The relationship between metabolic dysfunction-associated fatty liver disease and low muscle mass in an asymptomatic Korean population. J Cachexia Sarcopenia Muscle 13(6):2953–2960

Article  PubMed  PubMed Central  Google Scholar 

Ballesteros-Pomar MD, González-Arnáiz E, Pintor-de-la Maza B, Barajas-Galindo D, Ariadel-Cobo D, González-Roza L, Cano-Rodríguez I (2022) Bioelectrical impedance analysis as an alternative to dual-energy x-ray absorptiometry in the assessment of fat mass and appendicular lean mass in patients with obesity. Nutrition 93:111442

Article  PubMed  Google Scholar 

Achamrah N, Colange G, Delay J, Rimbert A, Folope V, Petit A, Grigioni S et al (2018) Comparison of body composition assessment by DXA and BIA according to the body mass index: a retrospective study on 3655 measures. PLoS ONE 13(7):e0200465

Article  PubMed  PubMed Central  Google Scholar 

Lee MM, Jebb SA, Oke J, Piernas C (2020) Reference values for skeletal muscle mass and fat mass measured by bioelectrical impedance in 390 565 UK adults. J Cachexia Sarcopenia Muscle 11(2):487–496

Article